Mental Health

China Medical University Hospital (CMUH) Explores ' BrainHealth ' to Scrutinize Dementia within a Minute

TAICHUNG, Taiwan, April 4, 2024 /PRNewswire/ -- In clinical practice, neurologists scrutinize dementia patients with using numerous tools, including medical history, blood tests, cognitive testing, mental assessment, medical imaging and electro-physiological signal testing. Patients usually spend...

2024-04-04 20:30 2395

"Click" for Joy, Connect for a Home: SONGMICS HOME Officially Launches Public Welfare Project with French Animal Protection Society La SPA

PARIS, Nov. 30, 2023 /PRNewswire/ -- SONGMICS HOME, a global-leading online furnishing brand serving 20 million households worldwide, has joined hands with France's oldest animal protection organization La Société Protectrice des Animaux ("La SPA") to officially kick off a long-term public welfare...

2023-12-01 10:45 1725

Wonder Tech's Breakthrough in Language Agnostic Voice AI to Bring Scalable Depression Screening to One Billion People Globally

SINGAPORE, Nov. 28, 2023 /PRNewswire/ -- Wonder Technologies PTE. LTD ("Wonder Tech" or "the Company"), a leading AI-driven mental health solutions company based inSingapore, has reached a breakthrough in its acoustics-based AI for depression screening. The AI model, which identifies depression t...

2023-11-29 00:00 1560

Jolly Good Inc. Establishes North American Subsidiary: Joint Development of Medical VR for "Apple Vision Pro" with U.S. Experts

~ First Phase: Joint Development of Chronic Pain VR with U.S. Chronic Pain Experts TOKYO, Nov. 1, 2023 /PRNewswire/ -- Jolly Good Inc. (Chuo-ku, Tokyo, CEO: Kensuke Joji, hereinafter referred to as Jolly Good), which develops and provides medical VR, announces that it has established a North Ame...

2023-11-01 21:00 1689

Emotional Link LLC CEO Naoto Sato Interviews Associate Professor Mai Uchida, Harvard Medical School, on "How to deal with Blowing up on SNS"

TOKYO, Sept. 27, 2023 /PRNewswire/ -- Emotional Link LLC , a business information dissemination company based inChuo Ward, Tokyo, has released an interview article with Associate ProfessorMai Uchida, Harvard Medical School, on "How to deal with Blowing up on SNS". ...

2023-09-27 22:00 2147

Growing Awareness of Brain Health for Senior Dogs as Cascade Animal Sciences Launches "Neuro-Pro"

ATLANTA, June 20, 2023 /PRNewswire/ -- Cascade Animal Sciences, an animal health start-up based inthe United States and Australia, is proud to announce the launch of its first dietary supplement product "Neuro-Pro".  Neuro-Pro is designed for middle-to-senior-aged dogs and dogs that require neuro...

2023-06-20 22:17 2051

MINDLAX REVOLUTIONIZES SLEEP SOLUTIONS WITH VIBROACOUSTIC SLEEPING MAT

The MindLax Sleeping Mat uses tactile-aural mechanisms that trigger the body's natural processes to induce relaxation and aid better sleep COLORADO SPRINGS, Colo., Feb. 20, 2023 /PRNewswire/ -- MindLax, the leading innovator in natural sleep and relaxation products and maker of the MindLax Sleep...

2023-02-21 00:00 1791

Actinogen announces first patient treated in depression and cognitive impairment Phase 2 clinical trial

Approximately 5% of Americans suffer from Major Depressive Disorder (MDD),[1]  which is commonly associated with "foggy thinking" but a new clinical trial raises hope that once-a-day oral drug Xanamem® may assist where treatment by anti-depressant medication alone is inadequate SYDNEY, Dec. 14, 2...

2022-12-14 21:52 1662

University of Tokyo and Sekisui House Launch Joint Research on Biodiversity and Health

- World's First Research into Relationship between Rich-in-Biodiversity Garden Greenery and Health/Well-being - TOKYO, Dec. 6, 2022 /PRNewswire/ -- The University of Tokyo's Graduate School of Agricultural and Life Sciences (GSALS) and Sekisui House, Ltd. launched a joint research project on bio...

2022-12-06 14:00 1385

Ybrain Receives Translational Research Award 2022 Neuroergonomics Conference & NYC Neuromodulation Conference

NEW YORK, Aug. 18, 2022 /PRNewswire/ -- Ybrain recently received the Translational Research Award at this year'sNeuroergonomics Conference and NYC Neuromodulation Conference held fromJuly 28 to August 1 for its neuromodulation technology in tran...

2022-08-18 20:00 1741

Announcing the Release of The Disruptors, the First Comprehensive Documentary Film on ADHD Award-Winning, Star-Studded Documentary Available in Australia on Apple TV/iTunes, Google Play, and YouTube

GREENWICH, Conn., Aug. 17, 2022 /PRNewswire/ -- Following its successful US debut, THE DISRUPTORS – the first definitive, comprehensive documentary film on ADHD, one of the most commonly diagnosed, and widely misunderstood neurological conditions in the world today – is now available inAustralia ...

2022-08-18 05:23 5017

Taiwanese Startup E-Kids Helps the Elderly with Butler Services Built on Psychotherapy Principles

* Butler-type service provides companionship and services such as tech assistance * Elderly are served by youths trained to communicate using psychotherapy principles * Psychotherapy matters a lot to many people all over the world, E-Kids to help deliver TAIPEI, July 28, 2022 /PRNewswire/ -...

2022-07-29 10:37 1542

THE WORLD'S FIRST ACADEMIC PAPER ON THE POTENTIAL USE OF VIRTUAL REALITY IN MODULATING PSYCHEDELIC-ASSISTED PSYCHOTHERAPY PUBLISHED BY THE CO-FOUNDERS OF ENOSIS THERAPEUTICS

The Peer-Reviewed Article Published In Volume 13 March 2022 Issue Of Frontiers In Psychology Journal Is A Landmark Examination Of Virtual Reality Therapy Combined With Psychedelic Therapy.  MELBOURNE, Australia, March 10, 2022 /PRNewswire/ -- The world's first scientific paper offering a careful...

2022-03-10 21:00 1523

Alterity Therapeutics Announces Publication Demonstrating that ATH434 is Neuroprotective in Animal Model of Parkinsonian Disorder in the Journal of Parkinson's Disease

MELBOURNE, Australia, Jan. 28, 2022 /PRNewswire/ -- Alterity Therapeutics (ASX: ATH, NASDAQ: ATHE) ("Alterity" or "the Company"), a biotechnology company dedicated to developing disease modifying treatments for neurodegenerative diseases, today announced that data in an animal model of Multiple S...

2022-01-28 20:08 1865

U.S. FDA Grants Bionomics Fast Track Designation to BNC210 for the Acute Treatment of Social Anxiety Disorder and Other Anxiety Related Disorders

ADELAIDE, Australia, Dec. 1, 2021 /PRNewswire/ -- Bionomics Limited (ASX:BNO, OTCQB:BNOEF) (Bionomics or Company), a clinical-stage biopharmaceutical company, is pleased to announce that the U.S. Food and Drug Administration (FDA) has granted Fast Track designation to the BNC210 development progr...

2021-12-01 19:00 2283

Paw for Good launches crowdfunding program to create a mutually beneficial ecosystem by transforming stray dogs into instructors for people with special needs

TAOYUAN, Taiwan, Sept. 9, 2021 /PRNewswire/ -- In September 2021, the Paw for Good team of Chung Yuan University Industry Accelerator and Incubator Center (IAIC) launched thePaw For Good Interactive Education Program in coope...

2021-09-10 13:37 1371

LG SIGNATURE Concludes Charity Auction Benefiting Families Affected by Autism

SEOUL, South Korea, July 22, 2021 /PRNewswire/ -- LG Electronics (LG) has pledged all proceeds from itsSTRONGER TOGETHER charity auction (July 8-18) to Sur les bancs de l'école, a French non-profit organization that has been supporting young people with Autism Spectrum Disorders (ASD) since 2008....

2021-07-23 09:00 8094

RBC Expands Global Youth Charity Program - RBC Charity Day for the Kids

* Virtual celebrations held by RBC Capital Markets employees in Canada, U.S., U.K.,France, Germany, Japan, Hong Kong, Australia, Barbados and Bahamas * US$5 million donated to over 50 charities worldwide SYDNEY, June 18, 2021 /PRNewswire/ -- As part of a global charitable initiative called RBC...

2021-06-17 20:00 1568

New Global Addiction Recovery and Overdose Prevention App

BETTER App Available for Download TODAY VANCOUVER, May 11, 2021 /PRNewswire/ -- A new mobile app has been developed to connect people around the world who are seeking recovery from addiction with a support community that wants to help - potentially saving lives.

2021-05-11 19:00 1158

Bionomics BNC210 Expansion into Social Anxiety Disorder

* Rapid oral absorption of BNC210 novel tablet formulation ideally suited for acute treatment of anxiety in patients with Social Anxiety Disorder * BNC210 Phase 2b PTSD trial on target for start in mid-2021 with U.S. CRO Premier Research selected and clinical site identification underway * P...

2021-05-10 18:00 2970
123